Steven Harold Goldman

Steven Harold Goldman discloses dealings in Stellar Pharmaceuticals Inc to SEC (Form 4). In total, 42 filings cover trades dated from 26 August 2010 to 27 February 2013.

In open-market terms, that means 13 purchases worth €497k on one side and 1 sale worth €179 on the other. On balance, insiders were net buyers of €497k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 26 share grants. In 2013 alone, the filings show 2 purchases and no sales.

In size, the median ticket on the buying side is €9,895.

The newest entry dates from 4 March 2013: an open-market purchase of €168k, in Stellar Pharmaceuticals Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.